These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22280536)

  • 1. Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.
    de Viron E; Michaux L; Put N; Bontemps F; Van Den Neste E
    Leuk Lymphoma; 2012 Aug; 53(8):1445-51. PubMed ID: 22280536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
    Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia.
    Carter A; Lin K; Sherrington PD; Atherton M; Pearson K; Douglas A; Burford A; Brito-Babapulle V; Matutes E; Catovsky D; Pettitt AR
    Leukemia; 2006 Apr; 20(4):737-40. PubMed ID: 16437137
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification.
    te Raa GD; Moerland PD; Leeksma AC; Derks IA; Yigittop H; Laddach N; Loden-van Straaten M; Navrkalova V; Trbusek M; Luijks DM; Zenz T; Skowronska A; Hoogendoorn M; Stankovic T; van Oers MH; Eldering E; Kater AP
    Cell Death Dis; 2015 Aug; 6(8):e1852. PubMed ID: 26247737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of SF3B1 mutations in CLL on the DNA-damage response.
    Te Raa GD; Derks IA; Navrkalova V; Skowronska A; Moerland PD; van Laar J; Oldreive C; Monsuur H; Trbusek M; Malcikova J; Lodén M; Geisler CH; Hüllein J; Jethwa A; Zenz T; Pospisilova S; Stankovic T; van Oers MH; Kater AP; Eldering E
    Leukemia; 2015 May; 29(5):1133-42. PubMed ID: 25371178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
    Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
    Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
    Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
    J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
    Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
    Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics.
    Amiel A; Arbov L; Manor Y; Fejgin M; Elis A; Gaber E; Lishner M
    Cancer Genet Cytogenet; 1997 Sep; 97(2):97-100. PubMed ID: 9283589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.
    Rigolin GM; del Giudice I; Formigaro L; Saccenti E; Martinelli S; Cavallari M; Lista E; Tammiso E; Volta E; Lupini L; Bassi C; Bardi A; Sofritti O; Daghia G; Cavazzini F; Marinelli M; Tavolaro S; Guarini A; Negrini M; Foà R; Cuneo A
    Genes Chromosomes Cancer; 2015 Dec; 54(12):818-26. PubMed ID: 26355802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of TP53 for CLL diagnostics.
    Catherwood MA; Gonzalez D; Donaldson D; Clifford R; Mills K; Thornton P
    J Clin Pathol; 2019 May; 72(5):343-346. PubMed ID: 30712002
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification.
    Stevens-Kroef M; Simons A; Gorissen H; Feuth T; Weghuis DO; Buijs A; Raymakers R; Geurts van Kessel A
    Cancer Genet Cytogenet; 2009 Dec; 195(2):97-104. PubMed ID: 19963108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia].
    Xu W; Li JY; Li L; Wu YJ; Yu H; Shen QD; Qiu HX
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):450-3. PubMed ID: 19035176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 protein expression in chronic lymphocytic leukemia.
    Sellmann L; Carpinteiro A; Nückel H; Scholtysik R; Siemer D; Klein-Hipass L; Kube D; Dürig J; Dührsen U; Stanelle J; Küppers R
    Leuk Lymphoma; 2012 Jul; 53(7):1282-8. PubMed ID: 22220854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia.
    te Raa GD; Malcikova J; Pospisilova S; Trbusek M; Mraz M; Garff-Tavernier ML; Merle-Béral H; Lin K; Pettitt AR; Merkel O; Stankovic T; van Oers MH; Eldering E; Stilgenbauer S; Zenz T; Kater AP;
    Leuk Lymphoma; 2013 Aug; 54(8):1849-53. PubMed ID: 23614766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
    Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
    Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.
    Hagenkord JM; Monzon FA; Kash SF; Lilleberg S; Xie Q; Kant JA
    J Mol Diagn; 2010 Mar; 12(2):184-96. PubMed ID: 20075210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part II. Trisomy 12 in B-cell chronic lymphocytic leukemia detected by fluorescence in situ hybridization].
    Wasik-Szczepanek E; Rupniewska ZM; Koczkodaj D; Bojarska A
    Pol Arch Med Wewn; 2003 Dec; 110(6):1431-8. PubMed ID: 15052938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.